Virginia’s Medicaid program, Cardinal Care, has chosen Humana Inc. HUM as one of five insurers to administer services through ...

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $243.33? Let's take a closer look at the ...

Humana (NYSE:HUM) has recently introduced Humana Healthy Horizons, a new Medicaid plan for Virginians under Cardinal Care, highlighting its focus on expanding in the Medicaid sector. This move ...

The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week as the U.S.

Shares of Humana Inc. (NYSE:HUM – Get Free Report) have received an average recommendation of “Hold” from the twenty-three ratings firms that are currently covering the firm, MarketBeat reports.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Today, Zacks Equity Research discusses The Cigna Group CI, Humana Inc. HUM, Centene Corp. CNC and Molina Healthcare, Inc. MOH ...

Humana is displaying robust revenue growth and expanding margins, driven by strong demand in core markets. Read more on why ...

This performance contributes to Humana’s impressive 10.1% revenue growth over the last twelve months, with the company generating a healthy 8% free cash flow yield. Strategic Initiatives and Growth ...

This performance contributes to Humana’s impressive 10.1% revenue growth over the last twelve months, with the company generating a healthy 8% free cash flow yield.

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.